Search research articles
Contact Us
Filters
Showing results (61-70 of 95) with videos related to
Page
of 10
Sort By:
Frontiers in Oncology
|
November 16, 2020
ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer <i>In Vitro</i>
Yingao Zhang, Yu Huang, Yajie Yin, et al.
Pregnancy Hypertension
|
April 21, 2026
Current postpartum management of hypertension: A survey of obstetricians, general practitioners, and midwives in the UK
Katherine Tucker, Holly Edmundson, Richard Stevens, et al.
Bioconjugate Chemistry
|
August 15, 2025
Effect of Click Chemistry Linkages on the Biological Behavior of Albumin-Binding <sup>177</sup>Lu-DOTAGA-pIBA-LLP2A Analogues Targeting Melanoma
Longbo Li, Aidan Wirrick, Michael D Pun, et al.
American Journal of Cancer Research
|
March 9, 2022
ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer
Katherine Tucker, Yajie Yin, Stuart-Allison Staley, et al.
Journal of Genetic Counseling
|
November 3, 2025
Views of genetic health professionals, patients, and next of kin on retesting and recontact with results from updated genetic testing
Alison Luk Young, Catherine Speechly, April Morrow, et al.
Frontiers in Oncology
|
April 4, 2022
Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer
Yali Fan, Jiandong Wang, Ziwei Fang, et al.
American Journal of Cancer Research
|
December 7, 2021
Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer
Allison Staley, Katherine Tucker, Yajie Yin, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer
Yu Huang, Yali Fan, Ziyi Zhao, et al.
Genome Medicine
|
June 26, 2014
Returning individual research results for genome sequences of pancreatic cancer
Amber L Johns, David K Miller, Skye H Simpson, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 9, 2021
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer
Stuart R Pierce, Ziwei Fang, Yajie Yin, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 95) with videos related to
Sort By:
Page
of 10
Frontiers in Oncology
|
November 16, 2020
ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer <i>In Vitro</i>
Yingao Zhang, Yu Huang, Yajie Yin, et al.
Pregnancy Hypertension
|
April 21, 2026
Current postpartum management of hypertension: A survey of obstetricians, general practitioners, and midwives in the UK
Katherine Tucker, Holly Edmundson, Richard Stevens, et al.
Bioconjugate Chemistry
|
August 15, 2025
Effect of Click Chemistry Linkages on the Biological Behavior of Albumin-Binding <sup>177</sup>Lu-DOTAGA-pIBA-LLP2A Analogues Targeting Melanoma
Longbo Li, Aidan Wirrick, Michael D Pun, et al.
American Journal of Cancer Research
|
March 9, 2022
ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer
Katherine Tucker, Yajie Yin, Stuart-Allison Staley, et al.
Journal of Genetic Counseling
|
November 3, 2025
Views of genetic health professionals, patients, and next of kin on retesting and recontact with results from updated genetic testing
Alison Luk Young, Catherine Speechly, April Morrow, et al.
Frontiers in Oncology
|
April 4, 2022
Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer
Yali Fan, Jiandong Wang, Ziwei Fang, et al.
American Journal of Cancer Research
|
December 7, 2021
Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer
Allison Staley, Katherine Tucker, Yajie Yin, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer
Yu Huang, Yali Fan, Ziyi Zhao, et al.
Genome Medicine
|
June 26, 2014
Returning individual research results for genome sequences of pancreatic cancer
Amber L Johns, David K Miller, Skye H Simpson, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 9, 2021
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer
Stuart R Pierce, Ziwei Fang, Yajie Yin, et al.
Page
of 10